Ostatní
Návod 
Vir Biotechnology, Inc.
VIR
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
0.7B
Obrat
0B
Zisk
0B
Aktiva
1B
Dluh
0B
ROE
0%
ROA
0%
PE
-3
PS
18
Cena 1R
4-11
⌀ Cena
5.51
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
Celoroční 10-K
Nadcházející oznámení zisků
25-02-2026
Poslední dividenda
Profil
Vir Biotechnology, Inc., společnost zabývající se imunologií v komerčním měřítku, vyvíjí terapeutické přípravky pro léčbu a prevenci závažných infekčních onemocnění. Vyvíjí se zde Sotrovimab (VIR- 7832), neutralizační mAbs SARS-CoV- 2 k léčbě a prevenci nákazy COVID-19 pod značkou Xevudy; VIR- 2218 a VIR- 3434 k léčbě viru hepatitidy B; VIR- 2482 k prevenci chřipky A a VIR- 1111 k prevenci viru lidské imunodeficience. Společnost uzavřela grantové dohody s nadací Bill & Melinda Gates Foundation a Národními zdravotnickými ústavy; opční a licenční smlouvu se společnostmi Brii Biosciences Limited a Brii Biosciences Offshore Limited; smlouvu o spolupráci a licenci se společností Alnylam Pharmaceuticals, Inc.; licenční smlouvy se společnostmi The Rockefeller University a MedImmune, Inc.; spolupráci se společnostmi WuXi Biologics a Glaxo Wellcome UK Ltd.; a smlouvu o spolupráci na výzkumu se společností GlaxoSmithKline Biologicals SA. Má také výrobní smlouvu se společností Samsung Biologics Co., Ltd. na výrobu protilátek proti SARS-COV-2 a klinickou spolupráci s firmou Gilead Sciences, Inc. na léčbu chronického viru hepatitidy B. Vir Biotechnology, Inc. byla založena v roce 2016 a sídlí v San Franciscu v Kalifornii.
Sektor
Healthcare
Odvětví
Biotechnology
Počet zaměstnanců
408
Založení
2019-10-11
Podobné společnosti
$ 3.05
+ $ 0.18
$ 2.48
+ $ 0.18
$ 8.66
+ $ 0.35
$ 3.67
- $ 0.15
$ 8.94
- $ 0.01
$ 1.11
+ $ 0.04
$ 10.02
+ $ 0.29
Zahraniční články
Výsledovka
Rozvaha
Peněžní toky
Výsledovka
Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
| Revenue | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 68.6 | 68.6 | 74.2 | 86.2 | 1,580.5 | 1,087.1 | 67.2 | 0.7 | 0.9 | 0.1 | |
| Cost of Revenues | 0.0 | 11.7 | 478.6 | 2.8 | 146.3 | 65.9 | 0.0 | 0.0 | -9.8 | 0.0 | |
| Gross Profit | 68.5 | 56.9 | -404.4 | 83.4 | 1,434.2 | 1,021.2 | 67.2 | 0.7 | 10.7 | 0.1 |
| Revenue | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 64.1 | 0.2 | 1.2 | 3.0 | 12.4 | 2.4 | 3.1 | 56.4 | 16.8 | -4.1 | |
| Cost of Revenues | -366.6 | 151.5 | 97.5 | 117.6 | 88.8 | 195.2 | 105.2 | 98.5 | 5.3 | 0.0 | |
| Gross Profit | 430.6 | -151.2 | -96.3 | -114.6 | -76.4 | -192.8 | -102.1 | -42.2 | 11.5 | -4.1 |
| Operating Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 589.7 | 474.6 | 448.0 | 302.4 | 148.5 | 100.2 | 62.5 | |
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 174.0 | 161.8 | 160.8 | 70.9 | 37.6 | 29.1 | 21.7 | |
| Depreciation & Amortization | 11.7 | 11.7 | 14.6 | 19.5 | 111.1 | 5.8 | 5.4 | 4.5 | 2.8 | 0.4 | |
| Total Operating Expenses | 536.6 | 524.9 | 182.7 | 767.7 | 601.1 | 600.5 | 364.2 | 178.7 | 119.6 | 81.6 | |
| Operating Income | -468.0 | -468.0 | -587.2 | -684.3 | 833.1 | 276.9 | -297.0 | -178.0 | -118.7 | -81.5 |
| Operating Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 89.5 | 148.3 | ||
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 39.1 | 41.1 | ||
| Depreciation & Amortization | 2.9 | 3.0 | 2.9 | 2.9 | 2.9 | 2.9 | 4.3 | 4.5 | 4.5 | 6.4 | ||
| Total Operating Expenses | 467.2 | 22.2 | 22.1 | 25.0 | 40.7 | 38.5 | 56.5 | 37.9 | 128.6 | 182.6 | ||
| Operating Income | -36.6 | -173.4 | -118.4 | -139.5 | -117.2 | -231.3 | -158.6 | -80.1 | -117.1 | -186.7 |
| Net Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 40.2 | 40.2 | 71.8 | 87.0 | 28.1 | 0.4 | 2.8 | 8.5 | 2.5 | 0.6 | |
| Interest Expense | 0.0 | 0.0 | 0.0 | 0.0 | 183.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Expense | 30.3 | 30.3 | 64.1 | 56.1 | -78.8 | 272.9 | -1.6 | 3.5 | -0.2 | 0.1 | |
| IBT | -437.8 | -437.8 | -523.1 | -628.2 | 754.3 | 549.8 | -298.6 | -174.5 | -116.4 | -80.8 | |
| Income Tax Expense | 0.2 | 0.2 | -1.1 | -13.1 | 238.4 | 21.2 | 0.1 | 0.2 | -0.5 | -10.9 | |
| Net Income | -438.0 | -438.0 | -522.0 | -615.1 | 515.8 | 528.6 | -298.7 | -174.7 | -115.9 | -69.9 |
| Net Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 7.8 | 9.4 | 10.8 | 12.3 | 14.2 | 17.5 | 18.8 | 21.3 | 20.7 | 21.9 | ||
| Interest Expense | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.2 | 0.0 | ||
| Other Expense | -6.4 | 10.5 | 7.6 | 18.6 | 12.5 | 17.8 | 18.7 | 15.1 | 18.3 | 20.1 | ||
| IBT | -43.1 | -163.0 | -110.8 | -120.9 | -104.7 | -213.5 | -139.9 | -65.0 | -120.8 | -166.6 | ||
| Income Tax Expense | -0.1 | 0.2 | 0.2 | 0.0 | -0.1 | 0.2 | -1.5 | 0.3 | -4.8 | -3.2 | ||
| Net Income | -42.9 | -163.1 | -111.0 | -121.0 | -104.6 | -213.7 | -138.4 | -65.3 | -116.0 | -163.4 |
| Per Share Data | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $-4.59 | $3.89 | $4.07 | $-2.51 | $-5.76 | $-1.20 | $-0.72 | |
| EPS Diluted | $0.00 | $0.00 | $0.00 | $-4.59 | $3.83 | $3.96 | $-2.51 | $-5.76 | $-1.20 | $-0.72 | |
| Shares Outstanding | 139.2 | 138.5 | 136.2 | 134.1 | 132.6 | 129.9 | 119.2 | 30.3 | 96.9 | 96.9 | |
| Diluted Shares Outstanding | 139.2 | 138.5 | 136.2 | 134.1 | 134.8 | 133.4 | 119.2 | 30.3 | 96.9 | 96.9 |
| Per Share Data | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-0.86 | $-1.22 | ||
| EPS Diluted | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-0.86 | $-1.22 | ||
| Shares Outstanding | 139.2 | 138.9 | 138.4 | 137.5 | 136.8 | 136.7 | 136.2 | 135.3 | 134.6 | 134.3 | ||
| Diluted Shares Outstanding | 139.2 | 138.9 | 138.4 | 137.5 | 136.8 | 136.7 | 136.2 | 135.3 | 134.6 | 134.3 |
| Current Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 310.8 | 222.9 | 254.8 | 848.6 | 347.8 | 436.6 | 109.3 | 47.6 | 187.9 | |
| Short Term Investments | 854.2 | 682.4 | 1,280.8 | 1,553.4 | 360.3 | 300.3 | 274.1 | 50.8 | 0.0 | |
| Total Cash & ST Investments | 1,165.0 | 905.3 | 1,522.4 | 2,402.0 | 708.1 | 736.9 | 383.4 | 98.4 | 187.9 | |
| Accounts Receivable | 7.2 | 0.0 | 0.0 | 0.0 | 773.1 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Inventory | 0.0 | 0.0 | 0.0 | 0.0 | 8.6 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Current Assets | 33.5 | 137.1 | 24.9 | 104.4 | 73.0 | 27.5 | 13.4 | 8.6 | 4.4 | |
| Total Current Assets | 1,205.7 | 1,042.5 | 1,588.2 | 2,519.1 | 1,562.8 | 772.4 | 403.0 | 117.8 | 192.4 |
| Current Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 170.1 | 211.1 | 273.6 | 222.9 | 168.4 | 296.9 | 160.7 | 254.8 | 452.1 | 666.9 | |
| Short Term Investments | 336.4 | 394.9 | 528.1 | 682.4 | 746.1 | 854.2 | 989.1 | 1,280.8 | 1,244.5 | 1,180.5 | |
| Total Cash & ST Investments | 506.5 | 606.0 | 801.7 | 905.3 | 914.5 | 1,151.1 | 1,149.8 | 1,535.7 | 1,696.6 | 1,847.4 | |
| Accounts Receivable | 0.0 | 0.0 | 0.0 | 5.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Inventory | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 8.4 | 0.2 | |
| Other Current Assets | 39.2 | 129.7 | 130.5 | 132.0 | 132.7 | 54.7 | 63.3 | 103.4 | 72.6 | 98.9 | |
| Total Current Assets | 545.7 | 735.7 | 932.2 | 1,042.5 | 1,047.2 | 1,205.7 | 1,213.1 | 1,588.2 | 1,769.2 | 1,946.3 |
| Long-Term Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 128.3 | 122.9 | 167.2 | 188.2 | 130.1 | 79.9 | 16.3 | 12.3 | 5.1 | |
| Goodwill | 16.9 | 16.9 | 16.9 | 16.9 | 16.9 | 16.9 | 16.9 | 16.9 | 16.9 | |
| Intangible Assets | 18.9 | 8.1 | 22.6 | 32.8 | 33.3 | 33.8 | 35.7 | 36.9 | 35.9 | |
| Long-Term Investments | 286.4 | 190.0 | 105.3 | 23.9 | 201.4 | 0.0 | 24.3 | 0.0 | 0.0 | |
| Other Long-Term Assets | 13.3 | 18.4 | 18.9 | 21.2 | 9.8 | 15.7 | 15.8 | 7.7 | 1.3 | |
| Total Long-Term Assets | 463.8 | 356.3 | 330.8 | 283.0 | 391.4 | 146.4 | 109.1 | 73.8 | 59.2 | |
| Total Assets | 1,669.6 | 1,398.8 | 1,919.1 | 2,802.1 | 1,954.3 | 918.8 | 512.1 | 191.6 | 251.6 |
| Long-Term Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 121.8 | 125.6 | 120.2 | 122.9 | 125.6 | 128.3 | 162.8 | 167.2 | 171.9 | 179.1 | |
| Goodwill | 16.9 | 16.9 | 16.9 | 16.9 | 16.9 | 16.9 | 16.9 | 16.9 | 16.9 | 16.9 | |
| Intangible Assets | 7.9 | 8.0 | 8.1 | 8.1 | 19.3 | 18.9 | 22.5 | 22.6 | 25.5 | 25.6 | |
| Long-Term Investments | 304.2 | 286.1 | 218.1 | 190.0 | 271.5 | 280.0 | 359.7 | 111.7 | 39.6 | 52.4 | |
| Other Long-Term Assets | 22.9 | 20.1 | 12.1 | 18.4 | 17.9 | 19.7 | 18.9 | 12.4 | 21.8 | 23.6 | |
| Total Long-Term Assets | 473.8 | 456.8 | 375.5 | 356.3 | 451.2 | 463.8 | 580.9 | 371.9 | 275.7 | 297.5 | |
| Total Assets | 1,019.5 | 1,192.5 | 1,307.7 | 1,398.8 | 1,498.4 | 1,669.6 | 1,794.0 | 1,960.1 | 2,044.9 | 2,243.9 |
| Current Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 4.4 | 5.1 | 6.3 | 6.4 | 6.5 | 5.1 | 5.9 | 6.5 | 4.9 | |
| Short-Term Debt | 19.5 | 7.8 | 12.9 | 4.1 | 3.9 | 3.9 | 0.2 | 14.5 | 0.0 | |
| Other Current Liabilities | 55.8 | 94.2 | 91.2 | 485.0 | 232.6 | 83.6 | 46.9 | 10.1 | 7.5 | |
| Current Liabilities | 96.4 | 119.7 | 175.4 | 511.0 | 341.2 | 99.1 | 59.2 | 39.9 | 12.4 |
| Current Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 6.8 | 12.2 | 3.7 | 5.1 | 7.3 | 4.4 | 7.1 | 6.3 | 3.6 | 12.4 | |
| Short-Term Debt | 9.0 | 8.8 | 7.9 | 7.8 | 19.4 | 19.5 | 11.9 | 12.9 | 13.6 | 13.5 | |
| Other Current Liabilities | 59.4 | 73.8 | 113.7 | 94.2 | 75.3 | 55.8 | 60.2 | 91.2 | 117.1 | 168.5 | |
| Current Liabilities | 75.2 | 105.0 | 137.3 | 119.7 | 117.2 | 96.4 | 94.1 | 175.4 | 165.1 | 225.6 |
| Long-Term Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 95.0 | 90.1 | 111.7 | 123.8 | 133.6 | 66.6 | 0.0 | 310.2 | 293.5 | |
| Capital Leases | 95.0 | 97.9 | 111.7 | 123.8 | 133.6 | 66.6 | 0.2 | 0.0 | 0.0 | |
| Def. Tax Liability | 0.0 | 0.0 | 0.0 | 3.3 | 18.4 | 3.3 | 3.3 | 3.3 | 3.3 | |
| Total Liabilities | 235.9 | 248.4 | 328.8 | 724.1 | 522.4 | 201.9 | 88.1 | 370.8 | 320.5 |
| Long-Term Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 91.2 | 93.4 | 88.2 | 90.1 | 93.4 | 95.0 | 109.2 | 111.7 | 114.1 | 117.8 | |
| Capital Leases | 100.2 | 102.2 | 96.1 | 97.9 | 112.8 | 114.5 | 121.1 | 111.7 | 114.1 | 117.8 | |
| Def. Tax Liability | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 43.2 | 0.0 | 0.0 | |
| Total Liabilities | 223.4 | 245.1 | 263.9 | 248.4 | 257.6 | 235.9 | 246.6 | 369.9 | 369.8 | 433.7 |
| Total Common Equity | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Retained Earnings | -441.5 | -759.8 | -237.8 | 377.2 | -138.6 | -667.2 | -368.5 | -193.8 | -78.0 | |
| Comprehensive Income | -2.9 | -1.7 | -0.8 | -9.1 | -1.1 | -1.3 | -0.6 | 0.0 | 0.0 | |
| Total Common Equity | 1,433.7 | 1,150.4 | 1,590.2 | 2,078.0 | 1,431.8 | 716.9 | 423.9 | -179.2 | -68.9 |
| Total Common Equity | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Retained Earnings | -1,154.8 | -991.7 | -880.7 | -759.8 | -655.2 | -441.5 | -303.1 | -237.8 | -121.9 | 41.6 | |
| Comprehensive Income | -1.9 | -2.2 | -2.0 | -1.7 | 1.1 | -2.9 | -2.4 | -0.8 | -1.9 | -2.9 | |
| Total Common Equity | 796.1 | 947.5 | 1,043.8 | 1,150.4 | 1,240.7 | 1,433.7 | 1,547.4 | 1,590.2 | 1,675.1 | 1,810.2 |
| Other | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 114.5 | 97.9 | 124.5 | 128.0 | 133.6 | 66.6 | 0.2 | 0.0 | 0.0 | |
| Book Value | 1,433.7 | 1,150.4 | 1,590.2 | 2,078.0 | 1,431.8 | 716.9 | 423.9 | -179.2 | -68.9 |
| Other | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Book Value | 796.1 | 947.5 | 1,043.8 | 1,150.4 | 1,240.7 | 1,433.7 | 1,547.4 | 1,590.2 | 1,675.1 | 1,810.2 |
| Cash Flow From Operating Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -483.0 | -438.0 | -522.0 | -615.1 | 515.8 | 528.6 | -298.7 | -174.7 | -115.9 | -69.9 | |
| Depreciation & Amortization | 17.8 | 21.2 | 14.6 | 19.5 | 6.8 | 5.8 | 5.4 | 4.5 | 2.8 | 0.4 | |
| Stock-Based Compensation | 101.1 | 49.1 | 78.5 | 111.3 | 102.1 | 83.8 | 27.6 | 8.7 | 5.1 | 4.8 | |
| Change Working Capital | -146.9 | -22.4 | -84.0 | -304.6 | 665.4 | -628.4 | 29.5 | 8.2 | 12.5 | 4.9 | |
| Change In Accounts Receivable | -4.4 | 0.0 | -6.5 | 0.0 | 770.0 | -773.1 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Change In Accounts Payable | -7.1 | 5.0 | -1.0 | 0.7 | 0.8 | -0.2 | -0.8 | 1.0 | 1.5 | 2.0 | |
| Change In Inventories | 251.4 | 0.0 | 0.0 | 0.0 | 0.0 | 52.8 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Non-cash Items | 291.4 | -1.6 | 69.5 | 11.2 | 388.4 | -52.6 | 45.2 | 8.9 | 2.0 | 4.3 | |
| Cash from Operations | -451.0 | 0.0 | 0.0 | -778.8 | 1,663.3 | -47.6 | -190.9 | -129.6 | -94.1 | -66.4 |
| Cash Flow From Operating Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -42.9 | -163.1 | -111.0 | -121.0 | -104.6 | -213.7 | -138.4 | -65.3 | -116.0 | -163.4 | |
| Depreciation & Amortization | 2.9 | 3.0 | 9.5 | 2.9 | 2.9 | 2.9 | 4.3 | 4.5 | 4.5 | 4.6 | |
| Stock-Based Compensation | 22.6 | 0.0 | 12.5 | 14.1 | 15.8 | 0.0 | 0.0 | 0.0 | 28.3 | 26.9 | |
| Change Working Capital | -2.8 | -20.6 | -25.1 | 26.1 | -17.0 | 17.5 | -2.4 | -82.1 | -32.7 | -29.7 | |
| Change In Accounts Receivable | 0.0 | 0.0 | 0.0 | 0.0 | -8.7 | -0.1 | 2.7 | -0.4 | -3.6 | -3.0 | |
| Change In Accounts Payable | 3.0 | -5.4 | 8.9 | -1.4 | -1.9 | 3.1 | -2.9 | 0.7 | 2.6 | -7.5 | |
| Change In Inventories | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 248.3 | 3.0 | |
| Other Non-cash Items | -5.6 | 13.2 | -6.2 | 0.0 | 17.9 | 21.8 | 59.0 | 33.5 | 9.1 | 172.4 | |
| Cash from Operations | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -107.9 | -155.8 |
| Cash Flow From Investing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -7.8 | -4.8 | -7.3 | -21.6 | -68.0 | -21.8 | -6.5 | -8.9 | -8.2 | -2.7 | |
| Acquisitions | 240.6 | 0.3 | 3.4 | 0.0 | 0.0 | 140.8 | 0.0 | 0.0 | 0.0 | -27.3 | |
| Investments | -2,156.2 | -886.3 | -1,235.3 | -2,016.2 | -1,477.0 | -420.2 | -403.8 | -643.9 | -123.1 | 0.0 | |
| Sales of Investment | 2,239.4 | 1,201.3 | 1,738.6 | 2,202.4 | 351.5 | 301.2 | 400.3 | 396.7 | 72.6 | 0.0 | |
| Other Investing Activities | -26.9 | 0.0 | 0.0 | 0.0 | 0.0 | -140.8 | 0.2 | 0.0 | -1.7 | 0.0 | |
| Cash from Investing | 76.3 | 0.0 | 0.0 | 164.6 | -1,193.5 | -140.8 | -9.9 | -256.2 | -60.4 | -30.0 |
| Cash Flow From Investing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | 4.5 | -0.3 | -2.5 | -1.6 | -2.4 | -2.4 | -0.7 | -1.9 | -1.5 | -3.7 | |
| Acquisitions | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.4 | 0.5 | 184.4 | 55.2 | |
| Investments | -255.8 | -264.4 | -192.4 | -173.7 | -160.9 | -240.1 | -271.4 | -562.9 | -819.0 | -502.9 | |
| Sales of Investment | 342.9 | 305.2 | 251.3 | 301.9 | 301.1 | 361.5 | 483.3 | 592.7 | 715.7 | 447.7 | |
| Other Investing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -184.4 | -55.2 | |
| Cash from Investing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -104.8 | -59.0 |
| Cash Flow From Financing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | -0.3 | 0.0 | 0.0 | -0.3 | -0.3 | -0.3 | -0.3 | -0.1 | 0.0 | 0.0 | |
| Debt Issued | -3.0 | 97.9 | -26.6 | -3.1 | -5.3 | 67.3 | 66.6 | 0.3 | 0.0 | 0.0 | |
| Issuance of Common Stock | 5.3 | 0.0 | 0.0 | 7.8 | 28.5 | 85.2 | 529.9 | 126.4 | 0.0 | 0.0 | |
| Repurchase of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 3.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Financing Activities | 3.9 | 0.0 | 0.0 | 7.8 | 3.3 | 15.4 | -0.2 | 322.9 | 25.0 | 271.2 | |
| Cash from Financing | 5.1 | 0.0 | 0.0 | 7.5 | 34.8 | 100.3 | 529.5 | 449.2 | 25.0 | 271.2 |
| Cash Flow From Financing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Debt Issued | 100.2 | -2.1 | 6.1 | -1.8 | -14.9 | -1.7 | -6.6 | -3.5 | 10.4 | -3.7 | |
| Issuance of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 1.8 | 0.3 | |
| Repurchase of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Financing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 1.7 | 0.3 | |
| Cash from Financing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 1.7 | 0.3 |
| Cash position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | -369.0 | -77.6 | 57.4 | -606.7 | 504.6 | -88.1 | 328.7 | 63.5 | -129.6 | 174.8 | |
| Closing Cash Balance | 310.8 | 241.1 | 318.7 | 261.3 | 868.0 | 363.4 | 451.5 | 122.8 | 59.4 | 188.9 |
| Cash position | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | 61.8 | -127.0 | -61.7 | 49.3 | 54.4 | -52.9 | 136.8 | -80.8 | -210.4 | -214.5 | |
| Closing Cash Balance | 234.1 | 172.3 | 306.3 | 368.0 | 318.7 | 257.9 | 310.8 | 174.0 | 254.8 | 472.4 |
| Free Cash Flow | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -458.8 | -396.6 | -453.7 | -800.4 | 1,595.2 | -69.4 | -197.5 | -138.6 | -102.3 | -69.1 | |
| Real Free Cash Flow | -559.9 | -445.7 | -532.1 | -911.7 | 1,493.1 | -153.2 | -225.1 | -147.3 | -107.3 | -73.9 |
| Free Cash Flow | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -21.4 | -167.9 | -122.8 | -79.7 | -90.0 | -173.8 | -78.5 | -111.3 | -109.5 | -159.5 | |
| Real Free Cash Flow | -44.0 | -167.9 | -135.2 | -93.8 | -105.9 | -173.8 | -78.5 | -111.3 | -137.7 | -186.5 |
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní
Nacenění
| Ukazatel | Aktuální | Historické | Konkurence |
|---|---|---|---|
| P/E | -2.9 | -8.5 | -1.4 |
| P/S | 18.5 | 439.4 | 9.4 |
| P/B | 1.6 | 3.1 | 5.2 |
| P/FCF | -2.9 | -10.4 | -1.5 |
| Market cap | $0.7 | $12.9 |
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.
Finance
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Debt to Assets | 0 % | 4.3 % | 0 % |
| Debt to Income | -22.9 % | -12 % | 0 % |
| Debt to Free cash flow | -22.7 % | -2675.4 % | 0 % |
| Interest expense percentage | 0 % | -0.1 % | 44.7 % |
| Current ratio | 7.3 | 6.3 | 0 |
Efektivita
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| ROE | -55 % | -13.1 % | 0 % |
| ROA | -43 % | -16.8 % | 0 % |
| CapEx to Revenue | 0 % | 353.1 % | 0 % |
| RaD to Revenue | 0 % | 4632.7 % | 0 % |
| ROEM | 168,029.4 | 684625.6 |
Marže
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Gross margin | 100 % | 4 % | 68.7 % |
| Operating margin | -699.2 % | -5596.6 % | 35.5 % |
| Net margin | -638.9 % | -5434 % | 9.5 % |
Dividenda
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Dividend yield | 0 % | 0 % | 0 % |
| Dividend payout percentage | 0 % | 0 % | 0 % |
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.
Ostatní
| Ukazatel | Aktuální | Historické |
|---|---|---|
| Shares outstanding | 139.2 mil | 125.0 mil |
| Employee count | 0.4 tis | 0.4 tis |
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
